Evidence map›Paper›PMID 16140987›Full record

ArticleGenes & development2005

Identification of the scaramanga gene implicates Neuregulin3 in mammary gland specification.

Beatrice Howard, Heena Panchal, Afshan McCarthy, Alan Ashworth

Open access · diamondAbstract read
In one paragraph

Article in Genes & development, 2005. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 46 papers.

0numbers the graph read from it
0cells of the map it votes in
46citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

46 citing papers in PubMed, 70 citations in OpenAlex.

  1. Article
  2. Review
  3. Review
  4. Embryonic Mammary Gland Morphogenesis.Advances in experimental medicine and biology · 2025
    Review
  5. Review
  6. Embryonic Programs in Cancer and Metastasis-Insights From the Mammary Gland.Frontiers in cell and developmental biology · 2022
    Review
  7. Review
  8. Article
  9. Review
  10. Review
  11. Review
  12. Article
  13. Article
  14. In-silico QTL mapping of postpubertal mammary ductal development in the mouse uncovers potential human breast cancer risk loci.Mammalian genome : official journal of the International Mammalian Genome Society · 2015
    Article
  15. Review
  16. Article
  17. Review
  18. Article
  19. Article
  20. Positional variations in mammary gland development and cancer.Journal of mammary gland biology and neoplasia · 2013
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 2 institutions in 1 country.

Beatrice HowardThe Breakthrough Breast Cancer Research Centre, Institute of Cancer Research, London SW3 6JB, United Kingdom. beatrice.howard@icr.ac.uk
Heena Panchal
Afshan McCarthy
Alan Ashworth
Breast Cancer Now · GBCancer Research UK · GB

Funding

Breast Cancer Now BREAST CANCER NOW RESEARCH CENTRE
6 · The paper itself

Abstract

The mouse scaramanga (ska) mutation impairs mammary gland development such that both abrogation and stimulation of gland formation occurs. We used positional cloning to narrow the interval containing scaramanga (ska) to a 75.6-kb interval containing the distal part of the Neuregulin3 (Nrg3) gene. Within this region the only sequence difference between ska and wild-type mice is in a microsatellite repeat within intron 7. This alteration correlates with variations in Nrg3 expression profiles both at the whole embryo level and locally in the presumptive mammary region in ska mice. Localized expression of Nrg3 and its receptor, Erbb4, in the presumptive mammary region around the future bud site prior to morphological appearance of buds and the expression of bud epithelial markers further support an inductive role. Finally, Neuregulin3 (Nrg3)-soaked beads can induce expression of the early bud marker Lef1 in mouse embryo explant cultures, and epithelial bud formation can be observed histologically, suggesting that initiation of mammary bud development occurs. Taken together, these results indicate that a Neuregulin signaling pathway is involved in specification of mammary gland morphogenesis and support the long-held view that mesenchymal signal(s) are responsible for mammary gland inductive/initiating events.

Indexed as

MutationAnimalsBase SequenceChoristomaCloning, MolecularDNA, ComplementaryErbB ReceptorsFemaleGene Expression ProfilingGene Expression Regulation, DevelopmentalGenes, erbB-2Intracellular Signaling Peptides and ProteinsMammary Glands, AnimalMesodermMiceMice, Inbred ADNA, ComplementaryErbb4 protein, mouseErbB ReceptorsIntracellular Signaling Peptides and ProteinsNeuregulinsNrg3 protein, mouseReceptor, ErbB-4

Identifiers

PMID16140987
PMCPMC1199577
OpenAlexW2144008094

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.